BAP1 and myelodysplastic syndrome: This is supported by the observation that specific loss of Bap1 in mouse hematopoietic progenitors is sufficient for the propagation of features of human MDS upon transplantation and by the identification of de novo BAP1 mutations in MDS patients (Dey et al., 2012).